View in EDS HTML Full Text PDF Full Text

Application of cinnarizine in migraine prevention: A systematic review and meta‐analysis.

Saved in:
Bibliographic Details
Title: Application of cinnarizine in migraine prevention: A systematic review and meta‐analysis.
Authors: Shafie'ei, Mohammad, Kouhanjani, Mohsen Farjoud, Akbari, Zahra, Sarvipour, Nastaran, Shekouh, Dorsa, Gholampour, Mohammadhasan, Ardestani, Pooneh Memar, Nemati, Hamid
Source: Pain Practice. Nov2022, Vol. 22 Issue 8, p733-745. 13p. 1 Black and White Photograph, 1 Diagram, 2 Charts, 4 Graphs.
Subjects: Migraine prevention, Online information services, Meta-analysis, Medical information storage & retrieval systems, English language, Confidence intervals, Propranolol, Calcium antagonists, Migraine, Systematic reviews, Analgesics, Activities of daily living, Treatment effectiveness, Placebos, Comparative studies, Disease duration, Quality of life, Descriptive statistics, MEDLINE, Valproic acid, Topiramate
Abstract: Objective: To investigate and analyze the available data on the prophylactic effectiveness of cinnarizine in migraine disorder. Background: Cinnarizine has demonstrated encouraging potential in preventing the attacks of migraine. Therefore, we opted to evaluate whether its sole administration leads to positive outcomes. Methods: The PubMed, Scopus, Web of Science, and Embase databases were searched for English‐only original interventional studies published until April 2022, then screened for relevancy and eligibility. The resulting data from the included studies, including the primary (ie, headache episode frequency, intensity, duration, monthly timing, and analgesic intake frequency) and secondary (ie, reported adverse events, quality of life, and activities of daily living) outcome changes compared to placebo and active controls (e.g., sodium valproate and propranolol) were then recorded by two independent assessors. Ultimately, these data were synthesized qualitatively and quantitatively (achieved by determining the mean difference via the random‐effects model). Results: A total of 10 studies comprising seven randomized controlled trials and three quasi‐experimental studies were included. Compared to placebo, cinnarizine demonstrated significant improvements in migraine episode frequency (Mean difference = −3.10; Confidence interval = [−3.33, −2.88]; p‐value < 0.001; I2 < 0.001%), and intensity (Mean difference = −1.54; Confidence interval = [−2.08, −0.99]; p‐value < 0.001; I2 < 37.97%). Moreover, cinnarizine led to similar or better results when compared to active controls, including sodium valproate, topiramate, and propranolol. Conclusions: Cinnarizine can be considered a safe and effective medication for migraine prophylaxis. However, the relatively small sample size made reaching a definite conclusion impossible. Therefore, a higher number of randomized controlled trials are recommended to be taken place to clarify the situation further. [ABSTRACT FROM AUTHOR]
Copyright of Pain Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 160097739
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Application of cinnarizine in migraine prevention: A systematic review and meta‐analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Shafie&#39;ei%2C+Mohammad%22&quot;&gt;Shafie&#39;ei, Mohammad&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Kouhanjani%2C+Mohsen+Farjoud%22&quot;&gt;Kouhanjani, Mohsen Farjoud&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Akbari%2C+Zahra%22&quot;&gt;Akbari, Zahra&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Sarvipour%2C+Nastaran%22&quot;&gt;Sarvipour, Nastaran&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Shekouh%2C+Dorsa%22&quot;&gt;Shekouh, Dorsa&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gholampour%2C+Mohammadhasan%22&quot;&gt;Gholampour, Mohammadhasan&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ardestani%2C+Pooneh+Memar%22&quot;&gt;Ardestani, Pooneh Memar&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Nemati%2C+Hamid%22&quot;&gt;Nemati, Hamid&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Pain+Practice%22&quot;&gt;Pain Practice&lt;/searchLink&gt;. Nov2022, Vol. 22 Issue 8, p733-745. 13p. 1 Black and White Photograph, 1 Diagram, 2 Charts, 4 Graphs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Migraine+prevention%22&quot;&gt;Migraine prevention&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Online+information+services%22&quot;&gt;Online information services&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Meta-analysis%22&quot;&gt;Meta-analysis&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Medical+information+storage+%26+retrieval+systems%22&quot;&gt;Medical information storage &amp; retrieval systems&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22English+language%22&quot;&gt;English language&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Confidence+intervals%22&quot;&gt;Confidence intervals&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Propranolol%22&quot;&gt;Propranolol&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Calcium+antagonists%22&quot;&gt;Calcium antagonists&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Migraine%22&quot;&gt;Migraine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Systematic+reviews%22&quot;&gt;Systematic reviews&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Analgesics%22&quot;&gt;Analgesics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Activities+of+daily+living%22&quot;&gt;Activities of daily living&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Treatment+effectiveness%22&quot;&gt;Treatment effectiveness&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Placebos%22&quot;&gt;Placebos&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Comparative+studies%22&quot;&gt;Comparative studies&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Disease+duration%22&quot;&gt;Disease duration&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Quality+of+life%22&quot;&gt;Quality of life&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Descriptive+statistics%22&quot;&gt;Descriptive statistics&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22MEDLINE%22&quot;&gt;MEDLINE&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Valproic+acid%22&quot;&gt;Valproic acid&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Topiramate%22&quot;&gt;Topiramate&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: To investigate and analyze the available data on the prophylactic effectiveness of cinnarizine in migraine disorder. Background: Cinnarizine has demonstrated encouraging potential in preventing the attacks of migraine. Therefore, we opted to evaluate whether its sole administration leads to positive outcomes. Methods: The PubMed, Scopus, Web of Science, and Embase databases were searched for English‐only original interventional studies published until April 2022, then screened for relevancy and eligibility. The resulting data from the included studies, including the primary (ie, headache episode frequency, intensity, duration, monthly timing, and analgesic intake frequency) and secondary (ie, reported adverse events, quality of life, and activities of daily living) outcome changes compared to placebo and active controls (e.g., sodium valproate and propranolol) were then recorded by two independent assessors. Ultimately, these data were synthesized qualitatively and quantitatively (achieved by determining the mean difference via the random‐effects model). Results: A total of 10 studies comprising seven randomized controlled trials and three quasi‐experimental studies were included. Compared to placebo, cinnarizine demonstrated significant improvements in migraine episode frequency (Mean difference = −3.10; Confidence interval = [−3.33, −2.88]; p‐value &lt; 0.001; I2 &lt; 0.001%), and intensity (Mean difference = −1.54; Confidence interval = [−2.08, −0.99]; p‐value &lt; 0.001; I2 &lt; 37.97%). Moreover, cinnarizine led to similar or better results when compared to active controls, including sodium valproate, topiramate, and propranolol. Conclusions: Cinnarizine can be considered a safe and effective medication for migraine prophylaxis. However, the relatively small sample size made reaching a definite conclusion impossible. Therefore, a higher number of randomized controlled trials are recommended to be taken place to clarify the situation further. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Pain Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=160097739
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/papr.13164
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 733
    Subjects:
      – SubjectFull: Migraine prevention
        Type: general
      – SubjectFull: Online information services
        Type: general
      – SubjectFull: Meta-analysis
        Type: general
      – SubjectFull: Medical information storage & retrieval systems
        Type: general
      – SubjectFull: English language
        Type: general
      – SubjectFull: Confidence intervals
        Type: general
      – SubjectFull: Propranolol
        Type: general
      – SubjectFull: Calcium antagonists
        Type: general
      – SubjectFull: Migraine
        Type: general
      – SubjectFull: Systematic reviews
        Type: general
      – SubjectFull: Analgesics
        Type: general
      – SubjectFull: Activities of daily living
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Placebos
        Type: general
      – SubjectFull: Comparative studies
        Type: general
      – SubjectFull: Disease duration
        Type: general
      – SubjectFull: Quality of life
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: MEDLINE
        Type: general
      – SubjectFull: Valproic acid
        Type: general
      – SubjectFull: Topiramate
        Type: general
    Titles:
      – TitleFull: Application of cinnarizine in migraine prevention: A systematic review and meta‐analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shafie'ei, Mohammad
      – PersonEntity:
          Name:
            NameFull: Kouhanjani, Mohsen Farjoud
      – PersonEntity:
          Name:
            NameFull: Akbari, Zahra
      – PersonEntity:
          Name:
            NameFull: Sarvipour, Nastaran
      – PersonEntity:
          Name:
            NameFull: Shekouh, Dorsa
      – PersonEntity:
          Name:
            NameFull: Gholampour, Mohammadhasan
      – PersonEntity:
          Name:
            NameFull: Ardestani, Pooneh Memar
      – PersonEntity:
          Name:
            NameFull: Nemati, Hamid
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 15307085
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Pain Practice
              Type: main
ResultId 1